Table 1.

Atherosclerosis and CHD Risk Variables According to Tertile of Baseline Antimullerian Hormone

	AMH Low (n = 22)	AMH Mid (n = 22)	AMH High (n = 22)	p
Iliac Artery Plaque Area (mm2)
Post-Treatment	0.76 ± 0.12	0.46 ± 0.1	0.34 ± 0.08	0.02
AMH (ng/ml)
Baseline Tertile Mean	4.94 ± 1.4	10.59 ± 1.3	21.3 ± 1.3	0.001
Tertile Range	0.96–7.6	7.71 – 14.4	14.6 – 50.6	NA
Estradiol (pg/ml)
Baseline	20.1 ± 5.3	21.6 ± 5.5	31.6 ± 5.3	0.3
Body weight (kg)
Baseline	3.2 ± 0.1	3.1 ± 0.1	3.1 ± 0.1	0.86
Post-Treatment	3.36 ± 0.2	3.31 ± 0.2	3.36 ± 0.2	0.97
TPC (mg/dl)
Baseline	245.1 ± 11	237.2 ± 13	235.2 ± 11	0.82
Post-Treatment	327.9 ± 16	290.9 ± 15	297.5 ± 17	0.23
HDLC (mg/dl)
Baseline	44.2 ± 3	45.8 ± 3	42.8 ± 3	0.8
Post-Treatment	44.7 ± 4	46.9 ± 4	43.3 ± 4	0.86
LDLC + VLDLC (mg/dl)
Baseline	199.5 ± 14	191.4 ± 13	192.5 ± 13	0.9
Post-Treatment	283.2 ± 18	244 ± 17	254.2 ± 19	0.3
TPC: HDLC
Baseline	6.2 ± 0.6	6.1 ± 0.6	6.0 ± 0.6	0.5
Post-Treatment	8.4 ± 0.7	7.4 ± 0.8	7.6 ± 0.8	0.56
LDLC + VLDLC: HDCL
Baseline	5.2 ± 0.6	5.1 ± 0.6	5.0 ± 0.6	1
Post-Treatment	7.4 ± 0.7	6.4 ± 0.7	6.6 ± 0.8	0.6

Baseline and 26 months post-diet measures of atherosclerosis, hormone and risk variable data are presented according to baseline (pre-treatment group assignment) tertiles of plasma AMH for all monkeys. Data are Mean ±SE.